Introduction: Prostate cancer is the leading urological cancer. It is the most common cancer in men over 50. Objective: To determine the epidemiological, diagnostic and therapeutic characteristics of prostate cancer in hospitals in the Thiès region. Patients and Methods: We conducted a descriptive study from January 1st, 2015 to December 31st, 2020. We included all cases of primary prostate cancer confirmed on histology. Results: We collected data on 318 cases of primary prostate cancer during the study period. Mean patient age was 72.7 years (Range: 49; 94 years). Family history of prostate cancer was found in 22 patients (6.91%). The average consultation time was 18.6 months. The circumstances of discovery were dominated by obstructive voiding disorders (97.16%). Digital Rectal examination was suggestive in 55.40% of patients. PSA level was above 20 ng/ml in 76.7% of patients. Prostatic adenocarcinoma was the only histological type (100%). Localized cancer represented 7.2% and locally advanced cancer occurred in 36.5% of cases, while metastatic cancer accounted for 56.3%. Radical prostatectomy was performed in 3.18% of cases. Mortality rate was estimated at 8.50% after 1 year. Conclusion: Prostate cancer is the leading urological cancer in the Thies region. It is characterized by the predominance of locally advanced and metastatic forms.
References
[1]
Siegel, R.L., Miller, K.D. and Jema, L.A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. https://doi.org/10.3322/caac.21551
[2]
Carioli, G., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., Negri, E., et al. (2020) European Cancer Mortality Predictions for the Year 2020 with a Focus on Prostate Cancer. Annals of Oncology, 31, 650-658. https://doi.org/10.1016/j.annonc.2020.02.009
[3]
Gueye, S.J.M., Labou, I., Niang, L., Kane, R. and Ndoye, M. (2004) Profil Clinique Du Cancer De La Prostate Au Sénégal. African Journal of Urology, 10, 203-207.
Diallo, Y., Kouka, S.C., Jalloh, M., et al. (2019) Metastatic Prostate Cancer: Clinical Aspects and Therapeutic Management in the Region of Thies, Senegal. Medical & Surgical Urology, 8, 224.
[6]
Gueye, S. (2014) Advanced Prostate Cancer in Senegal. Clinical Aspects at the General Hospital of Grand Yoff. Progrès en Urologie, 24, 271-275. https://doi.org/10.1016/j.purol.2013.08.317
[7]
Jalloh, M., Niang, L., Ndoye, M., Labou, I. and Gueye, S.M. (2013) Prostate Cancer in Sub Saharan Africa. Journal of Nephrology and Urology Research, 1, 15-20. https://doi.org/10.12970/2310-984X.2013.01.01.4
[8]
Cassell, A., Yunusa, B., Jalloh, M., et al. (2019) A Review of Localized Prostate Cancer: An African Perspective. World Journal of Oncology, 10, 162-168. https://doi.org/10.14740/wjon1221
[9]
Osegbe, D.N. (1997) Prostate Cancer in Nigerians: Facts and Non-Facts. Journal of Urology, 157, 1340-1343. https://doi.org/10.1016/S0022-5347(01)64966-8
[10]
Horwich, A., Parker, C., De Reijke, T., et al. (2013) Prostate Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 24, Vi106-Vi114. https://doi.org/10.1093/annonc/mdt208
[11]
Persaud, S., Goetz, L. and Burnett, A.L. (2017) Active Surveillance for Prostate Cancer: Is It Ready for Primetime in the Caribbean? African Journal of Urology, 23, 89-93. https://doi.org/10.1016/j.afju.2016.07.003
[12]
Kyei, M.Y., Mensah, E.J., Gepi-Attee, S., Kwami, D., Ampadu, K., Asante, E., Klufio, G.O., et al. (2013) Outcomes after Radical Prostatectomy in Ghanaians: A Surgeon’s Early Experience. ISRN Urology, 2013, Article ID: 832496. https://doi.org/10.1155/2013/832496
[13]
Ntama, A., Owon’Abessolo, P., Sango, A.J.F., Titti Mboumteke, J.G.F., Esson Mapoko, B.S., et al. (2023) épidémiologie et Diagnostic Du Cancer De La Prostate Dans La Ville De Douala (Cameroun). Health Sciences and Diseases, 24, 33-38. https://doi.org/10.4236/oju.2014.41002
[14]
Kabore, F.A., Zango, B., Kambou, T., Ouedraogo, A.S., Bam-Bara, A., Yameogo, C., et al. (2014) Prostate Cancer Disease Characteristics at the Time of Diagnosis and Initial Treatment Offered in a Tertiary Hospital at Ouagadougou (Burkina Faso). Open Journal of Urology, 4, 7-12.
[15]
Tengue, K., Kpatcha, T.M., Botcho, G., Leloua, E., Amavi, A.K., Sikpa, K., et al. (2016) Profil Epidemiologique, Diagnostique, Therapeutique et Evolutif Du Cancer De La Prostate Au Togo. African Journal of Urology, 22, 76-82. https://doi.org/10.1016/j.afju.2015.06.006
[16]
Ndiaye, M., Sow, O., Thiam, A., Sarr, A., Gaye, O. and Sine, B. (2020) Le Cancer De La Prostate Au Centre Hospitalier Universitaire Aristide Le Dantec De Dakar: Aspects épidémiologiques Sur Les Cinq Derniéres Années. Annales Africaines de Médecine, 14, e4004-e4009. https://anafrimed.net/cancer-de-la-prostate-au-centre-hospitalier-universitaire-aristidie-le-dantec-de-dakar-aspects-epidemiologiques-sur-les-cinq-dernieres-annees-prostate-cancer-in-aristide-le-dantec-hospital-of-dakar/
[17]
Xu, J. (2000) Combined Analysis of Hereditary Prostate Cancer Linkage to 1q24-25: Results from 772 Hereditary Prostate Cancer Families from the International Consortium for Prostate Cancer Genetics. The American Journal of Human Genetics, 66, 945-945. https://doi.org/10.1086/302807
[18]
Loeb, S. and Catalonia, W.J. (2009) What Is the Role of Digital Rectal Examination in Men Undergoing Serial Serum PSA Screening? Levels? Nature Clinical Practice Urology, 6, 68-69. https://doi.org/10.1038/ncpuro1294
[19]
Niang, L., Kouka, C.N., Jalloh, M. and Gueye, S.M. (2011) Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal. ISRN Oncology, 2011, Article ID: 943704. https://doi.org/10.5402/2011/943704
[20]
Descotes, J.L. (2019) Diagnosis of Prostate Cancer. Asian Journal of Urology, 6, 129-136. https://doi.org/10.1016/j.ajur.2018.11.007
[21]
Oranusi, C.K., Mbieri, U.T., Oranusi, I.O. and Nwofor, A.M. (2012) Prostate Cancer Awareness and Screening among Male Public Servants in Anambra State, Nigeria. African Journal of Urology, 18, 72-74. https://doi.org/10.1016/j.afju.2012.04.016
[22]
Nakandi, H., Kirabo, M., Semugabo, C., Kittengo, A., Ki-Tayimbwa, P., Kalungi, S. and Maena, J. (2013) Knowledge, Attitudes and Practices of Ugandan Men Regarding Prostate Cancer. African Journal of Urology, 19, 165-170. https://doi.org/10.1016/j.afju.2013.08.001
[23]
Fall, B., Sarr, A., Ouedraogo, B., Sow, Y., Thiam, A., Diallo, Y., et al. (2015) Detection Precoce Du Cancer De La Prostate Chez Des Apparentes De Premier Degre Au Senegal. African Journal of Urology, 21, 225-229. https://doi.org/10.1016/j.afju.2015.08.002
[24]
Cussenot, O. and Teillac, P. (1999) Cancer de la Prostate. Path Sciences, Paris, 616.
[25]
Ndoye, M., Niang, L., Gandaho, I.K., Jalloh, M., Labou, I. and Gueye, S.M. (2014) Cancer Avancé De La Prostate Au Sénégal. Aspects Diagnostiques á L’hôpital De Grand Yoff. Progrés en Urologie, 24, 271-275. https://doi.org/10.1016/j.purol.2013.08.317
[26]
Eifler, J.B., Feng, Z., Brian, M., Partin, M.T., Humphreys, E.B., Misop, H., et al. (2013) An Updated Prostate Cancer Staging Nomogram (Partin Tables) Based on Cases from 2006 to 2011. BJU International, 111, 22-29. https://doi.org/10.1111/j.1464-410X.2012.11324.x
Rozet, F., Hennequin, C., Beauval, J.B., Beuzeboc, P., Cormier, L., Fromont-Hankard, G., et al. (2018) French CcAFU Guidelines—Update 2018-2020: Prostate Cancer. Progrès en Urologie, 28, R81-R132. https://doi.org/10.1016/j.purol.2019.01.007
[29]
Hövels, A.M., Heesakkers, R.A., Adang, E.M., Jager, G.J., Strum, S., Hoogeveen, Y.L., et al. (2008) The Diagnostic Accuracy of CT and MRI in the Staging of Pelvic Lymph Nodes in Patients with Prostate Cancer: A Meta-Analysis. Clinical Radiology, 63, 387-395. https://doi.org/10.1016/j.crad.2007.05.022
[30]
Gandaglia, G., Ploussard, G., Valerio, M., Mattei, A., Fiori, C., Fossati, N., et al. (2019) A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-Targeted and Systematic Biopsies. European Urology, 75, 506-514. https://doi.org/10.1016/j.eururo.2018.10.012
[31]
Lecouvet, F.E., Simon, M., Tombal, B., Jamart, J., Vande Berg, B.C. and Simoni, P. (2010) Whole-Body MRI (WB-MRI) versus Axial Skeleton MRI (AS-MRI) to Detect and Measure Bone Metastases in Prostate. European Radiology, 20, 2973-2982. https://doi.org/10.1007/s00330-010-1879-3
[32]
Gutzeit, A., Doert, A., Froehlich, J.M., Eckhardt, B.P., Meili, A., Scherr, P., et al. (2010) Comparison of Diffusion-Weighted Whole Body MRI and Skeletal Scintigraphy for the Detection of Bone Metastases in Patients with Prostate or Breast Carcinoma. Skeletal Radiology, 39, 333-343. https://doi.org/10.1007/s00256-009-0789-4
[33]
Ruenes, A. and Gueye, S.M. (2008) Teaching Radical Prostatectomy in Sub-Saharan Africa. The Canadian Journal of Urology, 15, 3886-3889.
[34]
Babacar, S., Aissatou, B.N., Cyrille, Z.O., Amath, T., Alioune, S., Yaya, S., et al. (2018) Cancer de la Prostate Localisé à Haut Risque de Récidive: Résultats de la Prise Charge. African Journal of Urology, 24, 296-302. https://doi.org/10.1016/j.afju.2018.11.001
[35]
Niang, L., Ndoye, M., Ouattara, A., Jalloh, M., Labou, M., Thi-Am, I., Kouka, S.C., et al. (2013) Management of Prostate Cancer in Senegal: What Is Being Done? Progrès en Urologie, 23, 36-41. https://doi.org/10.1016/j.purol.2012.09.002
Heidenreich, A., Ohlmann, C.H. and Polyakov, S. (2007) Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical. European Urology, 52, 29-37. https://doi.org/10.1016/j.eururo.2007.04.020
[38]
Fall, B., Tengue, K., Sow, Y., Sarr, A., Ba, M. and Diagne, B.A. (2012) Place de la Pulpectomie Bilatérale Dans la Suppression Androgénique Pour Le Cancer de la Prostate. Progrès en Urologie, 22, 344-349. https://doi.org/10.1016/j.purol.2011.12.005
